Market Value279,042,000
Total Holdings46
File Date2022-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRVB / Provention Bio Inc
BYSI / BeyondSpring Inc. Call
RCKT / Rocket Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
859319303 / Sterling Financial Corp
BLU / Bellus Health Inc
GHRS / GH Research PLC
VTGN / Vistagen Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc. Call
RAPT / RAPT Therapeutics, Inc.
PARDES BIOSCIENCES INC / (69945Q105)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
CMRX / Chimerix, Inc.
DNAY / Codex DNA Inc
ALLK / Allakos Inc.
ALLO / Allogene Therapeutics, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
PRAX / Praxis Precision Medicines, Inc.
COGT / Cogent Biosciences, Inc.
OTIC / Otonomy Inc
CBIO / Crescent Biopharma, Inc.
IMUX / Immunic, Inc.
MLTX / MoonLake Immunotherapeutics
GBT / Global Blood Therapeutics Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Call
AVIR / Atea Pharmaceuticals, Inc.
MRNA / Moderna, Inc.
LPTX / Leap Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
ALEC / Alector, Inc.
ALDX / Aldeyra Therapeutics, Inc. Call
ALDX / Aldeyra Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
CASI / CASI Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
SRPT / Sarepta Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
DSGN / Design Therapeutics, Inc.
BLU / Bellus Health Inc Put
NMTR / 9 Meters Biopharma Inc
APLS / Apellis Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
SRRA / Sierra Oncology Inc
XENE / Xenon Pharmaceuticals Inc.
MRUS / Merus N.V.
ISEE / IVERIC bio Inc
ALNY / Alnylam Pharmaceuticals, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc. Call
CLDX / Celldex Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
ARVN / Arvinas, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.
CTIC / CTI BioPharma Corp
RETA / Reata Pharmaceuticals Inc - Class A
XENE / Xenon Pharmaceuticals Inc. Put
MRTX / Mirati Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
PCVX / Vaxcyte, Inc.
VRDN / Viridian Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
FOLD / Amicus Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CRNX / Crinetics Pharmaceuticals, Inc.